Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Estrella Immunopharma, Inc. (ESLA) Cash Flow from Investing Activities data is not available for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.29M |
|
-- |
|
-- |
|
$2.29M |
|
$-2.29M |
|
-- |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
$-2.29M |
|
42.12M |
|
42.12M |
|
$-0.05 |
|
$-0.05 |
|
| Balance Sheet Financials | |
$2.16M |
|
-- |
|
$1.50M |
|
$3.66M |
|
$8.93M |
|
-- |
|
-- |
|
$8.93M |
|
$-5.27M |
|
$-5.27M |
|
$-5.27M |
|
42.67M |
|
| Cash Flow Statement Financials | |
$-6.70M |
|
|
Cash Flow from Investing Activities |
-- |
$7.24M |
|
$1.38M |
|
$1.93M |
|
$0.54M |
|
$0.15M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.70M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
43.49% |
|
43.49% |
|
-62.67% |
|
43.49% |
|
$-0.12 |
|
$-0.16 |
|
$-0.16 |
|